Although universal access to antiretroviral therapy in Latin America has been accomplished in most countries of the region, a large proportion of HIV-infected individuals still present late for care and therefore initiate HAART with low CD4 counts and/or with an AIDS-defining event (ADE) [1]. This evidence concerns the gene CD4 and AIDS.